Times are stated in CEST (GMT + 2 / UTC + 2)
Every effort has been made to convert the IPVC 2020 scientific program into a fully virtual program. Thank you to all the presenters who have submitted their recordings in advance. These are available as on-demand webcasts in the interactive program on the virtual conference platform. Please note that some presenters were not able to pre-record their presentations, therefore there are still some sessions with missing presentations.
To view the pre-conference workshops, you need to register for them separately. Please contact: reg_ipvc20@kenes.com
You will then receive an email with instructions on how to login to the workshops’ platform.
Session Webcast
TAILORING TAILORED MESSAGES? EFFECTIVENESS OF TAILORED MESSAGES TO IMPROVE BEHAVIORAL INTENT TO ACCEPT HUMAN PAPILLOMAVIRUS (HPV) VACCINATION MAY BE MODERATED BY SOCIODEMOGRAPHIC FACTORS. (ID 913)
Webcast
INFLUENZA VACCINE VISITS ARE AN UNDERUTILIZED AVENUE FOR INCREASING HUMAN PAPILLOMA VIRUS VACCINATION RATES: AN AAP PEDIATRIC RESEARCH IN OFFICE SETTINGS (PROS) NETWORK STUDY (ID 1159)
- Alexander Fiks (United States of America)
- Peter Szilagyi (United States of America)
- Mary Kate Kelly (United States of America)
- Robert W. Grundmeier (United States of America)
- Alisa Stephens-Shields (United States of America)
- Russell Localio (United States of America)
- Laura P. Shone (United States of America)
- Margaret Wright (United States of America)
- Jennifer Steffes (United States of America)
- Abigail Breck (United States of America)
- Christina Albertin (United States of America)
- Sharon Humiston (United States of America)
- Cynthia Rand (United States of America)
- Dianna E. Abney (United States of America)
- Greta McFarland (United States of America)
Webcast
THE IMPORTANCE OF COMMUNITY ENGAGEMENT IN MANAGING THE RISK OF VACCINE HESITANCY IN A STUDY OF SINGLE-DOSE HPV VACCINATION (ID 1288)
Webcast
UNDERSTANDING DATA SYSTEMS THAT ENABLE ASSESSMENT OF THE IMPACT OF HPV VACCINATION IN HIGH-INCOME COUNTRIES (ID 1331)
Webcast
HPV VACCINE UPTAKE AND ASSOCIATED FACTORS IN ADULT WOMEN AGED UP TO 45 YEARS FROM 9 EUROPEAN COUNTRIES (COHEAHR-WP4 STUDY) (ID 1287)
- Claudia Robles (Spain)
- Laia Bruni (Spain)
- Mario Poljak (Slovenia)
- Matti Lehtinen (Sweden)
- Joakim Dillner (Sweden)
- Susanne K. Kjaer (Denmark)
- Karl Ulrich U. Petry (Germany)
- Marc Arbyn (Belgium)
- Jack Cuzick (United Kingdom)
- Christine Clavel (France)
- Silvia De Sanjose (United States of America)
- Francesc Xavier Bosch José (Spain)
AFTER THE SUSPENSION OF THE PROACTIVE HPV VACCINE RECOMMENDATION BY THE JAPANESE GOVERNMENT; WHAT HAPPENED AND WHAT IS HAPPENING IN JAPAN? (ID 458)
- Etsuko Miyagi (Japan)
- Kei Kawana (Japan)
- Yutaka Ueda (Japan)
- Asami Yagi (Japan)
- Takayuki Enomoto (Japan)
- Masayuki Sekine (Japan)
- Risa Kudo (Japan)
- Manako Yamaguchi (Japan)
- Kazuhiko Ino (Japan)
- Sayaka Ikeda (Japan)
- Tohru Morisada (Japan)
- Yukio Suzuki (Japan)
- Akiko Sukegawa (Japan)
- Taichi Mizushima (Japan)
- Tadashi Kimura (Japan)